Salute e Benessere

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024

UCART22 and UCART20x22: enrollment ongoing, Phase 1 dataset and late-stage development strategy to be presented in 2025AstraZeneca partnership: R&D activities are ongoing on three programs – one allogeneic CAR T for hematological malignancies, one allogeneic CAR T for solid tumors, and one in vivo gene therapy for a genetic disorderAppointed Adrian Kilcoyne, M.D., MPH, MBA, an industry leader in the advancement of cell therapy treatment, as Chief Medical OfficerCash...
Nasdaq GlobeNewswire
04/11/2024

David Meek is proposed as new Chair of the Board of Directors of Sobi

Annette Clancy has informed the Nomination Committee that she will not be available for re-election as Chair or ordinary member of the Board of Directors at the Annual General Meeting 2025. However, she will remain an ordinary member of the Board until that time. Annette Clancyhas informed the Nomination Committee that she will not be available for re-election as Chair or ordinary member of the Board of Directors at the Annual General Meeting 2025. However, she will remain an ordinary member...
PR Newswire
04/11/2024

Global Oncology Pharmaceuticals Market: Revolutionizing Cancer Care Worldwide

This report offers a detailed look at the global market for oncology pharmaceuticals, which are medications used to treat cancer. It covers different types of cancer drugs, including targeted therapies, immunotherapies, chemotherapies, and hormone therapies. The report also examines the market's current and past revenue, breaking it down by specific cancers like lung cancer, breast cancer, and others. This report offers a detailed look at the global market for oncology pharmaceuticals, which...
PR Newswire
04/11/2024

PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in…

GLORIA, the world's 1 stphase II phage therapy study in the treatment of Prosthetic Joint Infections (PJI) related to Staphylococcusaureus The clinical protocol also being submitted to the European health authorities and the MHRA in the UKPatients recruitment scheduled to start in Q1 2025 for clinical data readout expected in Q3 2026 Lyon (France), November 04, 2024 – 6:00 pm CET - PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), abiopharmaceutical company developing...
Nasdaq GlobeNewswire
04/11/2024

Reporting of transactions made by persons discharging managerial…

Company announcement no. 10 - 244 November 2024 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons...
Nasdaq GlobeNewswire
04/11/2024

Artificial Intelligence in Pathology Market to Hit USD 169.8 Million by 2029…

Browse in-depth TOC on "Artificial Intelligence in Pathology Market" Browse in-depth TOC on "Artificial Intelligence in Pathology Market" 250 - Tables 50 - Figures 300 - Pages By neural networks, the AI in pathology market is segmented into generative adversarial networks (GAN), convolutional neural networks (CNN), recurrent neural networks (RNN), and others. The convolutional neural network segment accounted for the largest share of AI in pathology market in 2023. The…
PR Newswire
04/11/2024

Home Automation System Market worth $73.49 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Home Automation System Market" 150 – Tables90 – Figures210 – Pages Browse in-depth TOC on "Home Automation System Market" 150 – Tables 90 – Figures 210 – Pages Home Automation System Market Report Scope: By Installation type: new installations segment to account for the larger market share in the forecasted year. The new installation segment accounted for the larger share of the home automation system market in 2029. The growth of the segment is...
PR Newswire
04/11/2024

KFSHRC Wins Gold and Four Bronze Stevie® Awards for Innovative Recruitment…

Attracting 4647 Talents Locally and Globally Over Two Years RIYADH, Saudi Arabia, Nov.04, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has been awarded a Gold and four Bronze awards at the Stevie ®International Business Awards in recognition of its efforts in human resources development and employee experience, as well as its adoption of innovative recruitment strategies, which contributed to attracting 4647 local and global talents over the...
Nasdaq GlobeNewswire
04/11/2024

New Meta-Analysis Strengthens Evidence That Nuts May Lower Cardiovascular Risk

The findings showed that, overall, nut consumption resulted in moderate reductions in total cholesterol and LDL ("bad") cholesterol, with small reductions in triglycerides and apolipoprotein B. There was no significant impact on HDL ("good") cholesterol or other assessed measures. The findings showed that, overall, nut consumption resulted in moderate reductions in total cholesterol and LDL ("bad") cholesterol, with small reductions in triglycerides and…
PR Newswire
04/11/2024

International and Regional Experts Address the Role of Vaccines in Disease…

According to the World Health Organization (WHO), vaccination is one of the most cost-effective ways to avoid diseases such as diphtheria, tetanus, pertussis, influenza, and measles. It has been estimated that vaccines can prevent 4 to 5 million deaths per year, with the ability to prevent 1.5 million more if global coverage of vaccines improves.i Today, more people benefit from vaccines to help prevent certain infectious diseases than ever before, providing essential health benefits at all…
PR Newswire
04/11/2024

MAMMOTION's LUBA 2 AWD Series Robot Lawn Mower Crowned as a TIME Best Invention…

"Being honored by TIME validates what our users have been saying — the best lawn is the one that you didn't have to cut yourself," said Jayden Wei, CEO of MAMMOTION. "We've reimagined what's possible by combining AI, precision engineering, and artistic capabilities into a solution that's transforming how people think about and maintain their outdoor spaces." "Being honored by TIME validates what our users have been saying — the best lawn is the one that you didn't have…
PR Newswire
04/11/2024

Philips enrolls first patient in U.S. clinical trial for innovative integrated…

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips' innovative laser system, marking a milestone in advancing personalized care for PAD patientsAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...
Nasdaq GlobeNewswire
04/11/2024

Renovaro Issues Shareholder Letter and Provides Corporate Update

Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today issued a letter to shareholders from Chief Executive Officer David Weinstein.Dear Shareholders,It is my honor to address you as the newly appointed CEO of Renovaro Inc. After careful consideration, I left a 40-year career on Wall Street to join Renovaro because I believe the Company has tremendous potential in its verticals, such as the dendritic cancer cell vaccine...
Nasdaq GlobeNewswire
04/11/2024

CATALYX AND INEL FORGE STRATEGIC PARTNERSHIP TO ADVANCE PACKAGING AUTOMATION IN…

INEL, a leader in printing, labeling, inspection, and serialization systems for the pharmaceutical industry, brings deep expertise in automation and tailored solutions. Its capabilities in electronics, computer science, and mechanical engineering ensure that INEL's products meet the rigorous demands of today's industrial environments. The company's extensive experience, combined with a state-of-the-art production facility in Slovenia, allows it to deliver innovative, customer-focused solutions…
PR Newswire
04/11/2024

Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a…

BigHat's AI/ML-powered antibody design platform, Milliner™, integrates a synthetic biology-based high-speed wet lab with state-of-the-art ML technologies into a full-stack antibody discovery and engineering platform, to engineer antibodies with more complex functions and better biophysical properties. This approach reduces the difficulty of designing antibodies and other therapeutic proteins to tackle conditions ranging from chronic illness to life-threatening disease, while also massively…
PR Newswire
04/11/2024

Trading by management and close relations of management

Announcement released on November 4, 2024 at 10:07:51 CET did not include PDF file. Please see the full announcement in the attached PDF file. Attachment 2024_44_Trading_By_Management
Nasdaq GlobeNewswire
04/11/2024

Affidea Group partners with Reset Health to launch clinically-led digital weight…

This new solution will be rolled out across Affidea markets in the coming period, offering patients access to a clinically proven, data-driven care pathway that combines advanced analytics with evidence-based interventions to improve health outcomes in managing obesity and its related chronic conditions. This new solution will be rolled out across Affidea markets in the coming period, offering patients access to a clinically proven, data-driven care pathway that combines advanced analytics…
PR Newswire
04/11/2024

Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and…

- Collaboration leverages Ascendis' proprietary TransCon ™technologies and Novo Nordisk's expertise in cardiometabolic diseases- Once-monthly GLP-1 receptor agonist will be the collaboration's lead product candidateCOPENHAGEN, Denmark, Nov.04, 2024(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo...
Nasdaq GlobeNewswire
04/11/2024

European Medicines Agency Confirms Acceptance of Marketing Authorization…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech's proposed biosimilar to Simponi® (golimumab), a biologic used to treat...
Nasdaq GlobeNewswire
04/11/2024

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine candidate BNT113 based on BioNTech's FixVac platform Initiated two Phase 2 dose optimization trials with BNT327/PM8002 in small-cell lung cancer and in triple-negative breast cancer to inform planned pivotal Phase 3 trialsPhase 2 clinical trial on track to evaluate mRNA-based individualized cancer vaccine candidate autogene cevumeran...
Nasdaq GlobeNewswire
04/11/2024

Acclaro Medical Announces Opening of New Headquarters in Munich, Germany

An important player in the aesthetic laser business since 2018, Acclaro is enthusiastic and prepared to leverage the full potential of its UltraClear fiber laser with new and existing partners in the European Union. According to Reiner Kuchenbaur, Managing Director of Acclaro Medical GmbH, a wholly owned subsidiary of Acclaro Corporation, "the establishment of new corporate headquarters in Munich is a key progressive strategy that will help accelerate the exchange of clinical experiences…
PR Newswire
04/11/2024

Åsa Manelius Named Managing Director of Novavax AB Site

"Åsa brings deep global operations knowledge to Novavax during a critical time of transition for the Company," said Rick Crowley, Chief Operations Officer, Novavax. "As we focus on driving value via our proven technology platform through partnerships and R&D, Åsa and our AB site will be critical to ensuring robust supply of our best-in-class Matrix-M™ adjuvant for both our pipeline and potential partners." "Åsa brings deep global operations knowledge to Novavax…
PR Newswire
04/11/2024

Buyback of Class B shares in Essity during week 44, 2024

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
04/11/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2024

Accumulated revenue for January – October 2024 increased by 21 % to SEK 1691.7 (1402.4) million. Accumulated revenue for January –October 2024increased by 21 % toSEK 1691.7(1402.4) million. Revenues were distributed as follows: Countries in regions:-The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden- Central Europe :Austria,Germany,Switzerland- East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania-South &West...
PR Newswire
04/11/2024
Altri  Comunicati